Cohort Study of Metabolic Disease and Hypertension
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorCoordinación de Investigación en Salud, Mexico
About this trial
The goal of this observational study is to learn how type 2 diabetes and high blood pressure develop over time in adults in Mexico. The study will include men and women between 18 and 65 years of age who do not have a previous diagnosis of these conditions.
The main questions this study aims to answer are:
What factors increase the risk of developing type 2 diabetes? What factors increase the risk of developing high blood pressure?
Participants will not receive any experimental treatment. Researchers will observe their health as part of their regular medical care.
Participants will:
Attend an initial visit that includes physical measurements, blood tests, and questionnaires about their health, lifestyle, and environment Perform a simple walking test to measure physical fitness Return once a year for follow-up visits over a period of five years
During the study, researchers will monitor participants to identify new cases of type 2 diabetes and high blood pressure.
The results of this study may help improve prevention strategies and support public health programs aimed at reducing chronic diseases in Mexico.
Eligibility criteria
Qualifiers
Adults aged 18 to 65 years
No prior diagnosis of type 2 diabetes mellitus or hypertension
Receiving care at primary health care units of the Mexican Social Security Institute (IMSS) or IMSS-Bienestar
Willing and able to provide informed consent
Disqualifiers
Prior diagnosis of type 2 diabetes mellitus or hypertension
Pregnancy at the time of enrollment
Any condition that limits the ability to perform study procedures, including the six-minute walk test
Any condition that, in the opinion of the investigators, may interfere with participation or follow-up
Trial design
Treatments tested in this trial
- Observational Study
Treatment groups
2,500 Participants
are divided into 1 treatment groupSponsors and collaborators
Coordinación de Investigación en Salud, Mexico
Lead sponsor
Secretaria de Salud, Mexico
Collaborator
Instituto Mexicano del Seguro Social
Collaborator
Source ClinicalTrials.gov